Tag Archives: weight loss medications

Contrave will be available at pharmacies starting October 20th. It is FDA-approved for individuals with a BMI over 30, or over 27 with a weight-related health problem like high cholesterol, high blood pressure or diabetes. It is approved for chronic use – that means it has been studied and approved for long-term weight control, similar to how we use medications for high cholesterol and for diabetes. [Read more]

Contrave, otherwise known as NB32, is finally getting the opportunity to help individuals lose weight in the United States. The diet drug was rejected by the U.S. Food and Drug Administration (FDA) when it was first introduced in 2011 due to lack of solid data about heart risk. However, it is getting a second chance, as it successfully went through a preliminary stage in June 2014, and is expected to gain final approval in September 2014. [Read more]

Belviq (Lorcaserin) cleared its final regulatory hurdle and has now received approval from the FDA and clearance from the DEA. This means it should be available to Denver weight loss patients in about a month (e.t.a. June, 2013). [Read more]

A randomized placebo controlled trial called SCOUT (Sibutramine Cardiovascular Outcomes Trial) was launched in 2002 and enrolled over 10,000 overweight or obese individuals with diabetes or a history of coronary or peripheral vascular disease or stroke, along with other CV risk factors. At the conclusion of the trial, an early analysis for the trial’s primary […]